Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 7, 2016

View Archived Issues

Lion Biotechnologies submits IND to study LN-145 in cervical, head and neck cancer

Novel biomarker described for congenital disorders of glycosylation

Gilead Sciences discloses PI3K inhibitors

VenatoRx Pharmaceuticals presents beta-lactamase inhibitors

University of Arizona reports melanocorin receptor modulators

Inovio reports results from phase IIb trial of VGX-3100 in cervical intraepithelial neoplasia

NIAID reports results from phase I trial of VRC-01 in people with HIV infection

Vernalis confirms Corvus Pharmaceuticals as licensee for adenosine antagonist program

GSK selects first ImmTAC clinical candidate from Immunocore collaboration

Complix collaborates with Merck & Co. to develop Cell-Penetrating Alphabodies

Oncodesign Biotechnology and Bristol-Myers Squibb form strategic drug discovery collaboration

Gilead terminates phase II study of simtuzumab in idiopathic pulmonary fibrosis

Enterome Bioscience forms gastrointestinal drug discovery collaborations

FDA grants orphan drug designation to anthracycline GPX-150 for soft tissue sarcoma

Dimension Therapeutics' gene therapy DTX-301 granted FDA orphan drug designation

Petra Pharma launched to develop small-molecule drugs for cancer and metabolic disorders

Sensorion cleared to initiate phase I trial of SENS-218 in U.K.

ONT-380 plus T-DM1 shows antitumor activity in MBC

FDA grants fast track designation to seviteronel for metastatic CRPC

FDA awards breakthrough therapy designation to VTS-270 for Niemann-Pick type C1 disease

Sanofi to stop selling MannKind inhaled insulin

Vical's VL-2397 wins FDA orphan drug designation for invasive aspergillosis

OXiGENE's CA4P receives U.S. orphan drug designation for neuroendocrine tumors

Ardelyx reports data for RDX-022 in the treatment of hyperkalemia

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...